Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 2/20 | 0.50 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.50 |
| ▸ | PRCP | P42785 | 3/20 | 0.49 |
| ▸ | HTR2C | P28335 | 4/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | TERT | O14746 | 2/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28982454 | 0.81 | TBXAS1 (0.44) | CCNKCDK12HTR2CHTR2BTERT | |
| SCHEMBL18381308 | 0.80 | SMN1; SMN2 (0.41) | TERTTBXAS1 | |
| SCHEMBL15329272 | 0.76 | PRCP (0.70) | CCNKCDK12PRCPHTR2CHTR2B | |
| SCHEMBL31339174 | 0.75 | EPHX1 (0.57) | CCNKCDK12PRCP | |
| SCHEMBL8057395 | 0.75 | PRCP (0.48) | CCNKCDK12PRCPHTR2CHTR2B | |
| SCHEMBL3208254 | 0.75 | PRCP (0.48) | CCNKCDK12PRCPHTR2CHTR2B | |
| SCHEMBL19051487 | 0.75 | EPHX1 (0.57) | CCNKCDK12PRCP | |
| SCHEMBL2089398 | 0.75 | HTR2C (0.60) | PRCPHTR2CHTR2B | |
| SCHEMBL2089397 | 0.75 | HTR2C (0.60) | PRCPHTR2CHTR2B | |
| SCHEMBL2089855 | 0.75 | HTR2C (0.60) | PRCPHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119300804-A | Composition for improving skin wrinkles, improving skin texture or whitening comprising a retinoid and a retinoid enhancer | 株式会社LG生活健康 | 2025-01-10 | — | — | CN | claimed |
| WO-2023249305-A1 | COMPOSITION FOR SKIN WRINKLE IMPROVEMENT, SKIN TEXTURE IMPROVEMENT OR WHITENING CONTAINING RETINOID AND RETINOID BOOSTER | 주식회사 엘지생활건강 | 2023-12-28 | — | — | WO | claimed |
| CN-119300804-A | Composition for improving skin wrinkles, improving skin texture or whitening comprising a retinoid and a retinoid enhancer | 株式会社LG生活健康 | 2025-01-10 | — | — | CN | disclosed |
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| WO-2023249305-A1 | COMPOSITION FOR SKIN WRINKLE IMPROVEMENT, SKIN TEXTURE IMPROVEMENT OR WHITENING CONTAINING RETINOID AND RETINOID BOOSTER | 주식회사 엘지생활건강 | 2023-12-28 | — | — | WO | disclosed |
| CN-115778862-A | Make-up base and preparation method thereof | 周嘉奇 | 2023-03-14 | — | — | CN | disclosed |
| US-11413231-B2 | Cosmetic hair dyeing and/or bleaching composition, method, use and kit thereof | REVLON CONSUMER PRODUCTS CORPORATION (US) | 2022-08-16 | — | — | US | disclosed |
| CN-108495646-B | Compound for treating and/or caring for skin, hair, nails and/or mucous membranes | 路博润先进材料公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-105147563-A | Anti-glycation particles used for powder-type cosmetics and preparation method thereof | PROYA COSMETICS CO LTD | 2015-12-16 | — | — | CN | disclosed |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008107347-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, MTX1, MTX2 | CCNK 1853/4885CDK12 4113/4885PRCP 3528/4885 |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | CCNK 278/4885CDK12 664/4885PRCP 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.